Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy (Q51831972)
scientific article published on 15 November 2005
Language:
Current Data About Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy
(P31) (Q13442814)
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

(P304) 99-104
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

(P433) 2
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

(P478) 132
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

(P577) Tuesday, November 15, 2005
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

(P921) (Q715347)

(Q181600)

(Q29496)
(P887)

(Q1088156)
(P887)

(Q425745)
(P887)

(P1433) (Q2081599)
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

(P1476) "Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy" (language: en)
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

(P2093) T Lissitchkov
(P1545) 1
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

G Arnaudov
(P1545) 2
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

D Peytchev
(P1545) 3
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

Kh Merkle
(P1545) 4
(P248)
(P698) 16292542
(P813) Friday, April 13, 2018
(P854) http://europepmc.org/abstract/MED/16292542

(P2860) (Q34526094)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/16292542
(P813) Saturday, December 12, 2020
(P887)

(Q34734956)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/16292542
(P813) Saturday, December 12, 2020
(P887)

(Q34382878)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/16292542
(P813) Saturday, December 12, 2020
(P887)

(Q44096414)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/16292542
(P813) Saturday, December 12, 2020
(P887)

(Q32019548)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/16292542
(P813) Saturday, December 12, 2020
(P887)

other details
description scientific article published on 15 November 2005

External Links
(P356) 10.1007/S00432-005-0050-Z
(P698) 16292542